LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?

Leucine rich repeat proteins have gained considerable interest as therapeutic targets due to their expression and biological activity within the central nervous system. LINGO-1 has received particular attention since it inhibits axonal regeneration after spinal cord injury in a RhoA dependent manner...

Descripción completa

Detalles Bibliográficos
Autores principales: Foale, Simon, Berry, Martin, Logan, Ann, Fulton, Daniel, Ahmed, Zubair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607814/
https://www.ncbi.nlm.nih.gov/pubmed/28966634
http://dx.doi.org/10.4103/1673-5374.213538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607814/
https://www.ncbi.nlm.nih.gov/pubmed/28966634
http://dx.doi.org/10.4103/1673-5374.213538

Ejemplares similares